The Use of an Interleukin-6 Inhibitor in Vasoplegic Shock from Severe Systemic Inflammatory Response Syndrome: A Case Report.
Elkhatib WY, Saunders H, Helgeson SA, Moss JE.
Elkhatib WY, et al. Among authors: helgeson sa.
Indian J Crit Care Med. 2021 Aug;25(8):939-941. doi: 10.5005/jp-journals-10071-23943.
Indian J Crit Care Med. 2021.
PMID: 34733038
Free PMC article.
We have shown for the first time that therapy with tocilizumab is effective in reversing the hemodynamic instability associated with the significant systemic inflammatory response from the "double hit" of CMML and coronary artery bypass grafting with cardiopulmonary bypass as has …
We have shown for the first time that therapy with tocilizumab is effective in reversing the hemodynamic instability associated with the sig …